messag updat estim dplo follow
recent report result maintain pt rais
pt maintain dplo pt rais pt
tweak revenue/adjust ebitda estim
 previous
introduc revenue/adjust ebitda estim
updat estim reflect impact result revis outlook
remaind
tweak revenue/adjust ebitda estim
 previous updat
estim reflect impact result revis outlook remaind
dplo tweak revenue/adjust ebitda estim
 previous updat estim reflect impact
result revis outlook remaind
tweak revenue/adjust ebitda estim
 previous updat estim reflect
impact result revis outlook remaind
page analyst certif import disclosur
valuat risk
maintain price target base ev/ebitda slightli higher multipl vs
previou valuat reflect improv perform core pharmaceut distribut busi valuat reflect
discount suppli chain peer trade view appropri given recent mix execut particularli
medic segment also reflect discount five-year histor averag view appropri given
structur concern surround busi maintain neutral rate risk upsid potenti better
expect gener brand price environ anoth risk upsid potenti acceler recoveri compani
medic divis risk downsid potenti regulatori reform may neg impact distributor econom anoth
risk downsid potenti acceler concern regard outcom opioid litig
rais price target previous base share eventu trade ebitda
in-lin previou target multipl valuat repres premium suppli chain peer gener trade
believ warrant given improv fundament diversifi natur busi maintain buy rate risk
downsid potenti execut issu given magnitud integr aetna anoth risk downsid
potenti acceler reimburs pressur retail pharmaci busi
dplo maintain price target base share eventu trade ebitda vs previou
target multipl higher multipl vs previou valuat reflect greater confid compani strateg valu given
recent announc consid strateg altern includ merger sale valuat repres discount
five year histor averag believ warrant given structur concern surround busi maintain
neutral rate risk downsid continu structur pressur specialti pbm busi anoth risk
downsid lower expect brand inflat risk upsid potenti faster expect recoveri recent
custom loss anoth risk upsid potenti acceler improv reimburs environ
rais price target prior base ev/revenu higher multipl vs
previou target valuat reflect higher level confid compani servic offer follow strong result
valuat repres premium hcit peer gener trade given above-averag growth rate maintain
neutral rate risk downsid potenti lower anticip end-market demand support compani financi
target anoth risk downsid potenti medic safeti solut fall client invest prioriti risk
upsid potenti acceler progress compani cross-sel initi anoth risk upsid potenti
acceler margin improv compani mix servic busi increas
page analyst certif import disclosur
compani file guggenheim secur llc estimt
page analyst certif import disclosur
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic
inc health corpor diplomat pharmaci inc inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori cardin inc
rate price target histori health corpor
creat bluematrix
creat bluematrix
page analyst certif import disclosur
rate price target histori diplomat pharmaci inc dplo
rate price target histori inc
creat bluematrix
creat bluematrix
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
nr invest rate price target temporarili suspend suspens complianc applic regul and/or
cs coverag suspend guggenheim secur llc suspend coverag compani
nc cover guggenheim secur llc cover compani
monitor describ stock whose compani fundament financi monitor financi project opinion
invest merit compani provid
review ur follow releas signific news compani rate temporarili place review suffici
inform obtain assess analyst
guggenheim secur llc methodolog assign rate may includ follow market capit matur growth/valu volatil
expect total return next month price target base sever methodolog may includ restrict analys
market risk growth rate revenu stream discount cash flow dcf ebitda ep cash flow cf free cash flow ev/ebitda price-to-earnings pe/growth
price-to-cf p/fcf premium discount /averag group ev/ebitda premium discount /averag group price-to-earnings sum part net asset valu dividend return
return equiti roe next month
price target assign buy- sell-rat stock price target neutral-r stock provid discret analyst
page analyst certif import disclosur
